article thumbnail

Case Report: Kounis syndrome associated with urticaria following COVID-19 infection

Frontiers in Cardiovascular Medicine

Subsequent nucleic acid testing confirmed the presence of COVID-19 infection, prompting the initiation of anti-allergic and supportive therapies.

article thumbnail

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

Coronary Artery Disease Journal

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.

article thumbnail

The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample

Coronary Artery Disease Journal

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Patients with COVID-19 versus those without had significantly greater in-hospital mortality (45.2% reduction in admissions in 2020.

article thumbnail

Impact of COVID-19 on Digital Cardiology Care

SoftCath

Since the onset of COVID-19, cardiology care has been under extreme risk and adverse complications. So, let’s unwind how the innovations in cath lab software are reshaping the method of cardiovascular care post-Covid-19. Cath lab management software , which existed even before COVID-19, experienced updates and upgrades.

article thumbnail

Impact of the COVID-19 pandemic on acute coronary syndrome hospital admission and management in Slovenia

Open Heart

Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. Data on 21 001 patients were included (7057 ST-elevation myocardial infarction (STEMI), 7649 non-ST elevation myocardial infarction (NSTEMI) and 6295 unstable angina).

article thumbnail

Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran

The British Journal of Cardiology

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.

article thumbnail

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Circulation: Cardiovascular Quality & Outcomes

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. 3.48]), and diagnoses of COVID-19 (odds ratio, 1.74 [95% CI, 1.11–2.71]) T1MI and 53.5% T2MI; mean age, 79±10.3 years; 47% female).